A group of nine pharmacy benefit managers (PBMs) announced Thursday that they will work with an industry group to boost the transparency of prescription drug pricing through the TrumpRx platform.

FOX Business exclusively learned that the Pharmaceutical Care Management Association (PCMA) and nine PBMs reached an agreement to showcase the cash price of prescriptions from TrumpRx within their benefit tools. The agreement aims to give patients better visibility into the cost of the medication and how they might save money on it.

“President Trump has made lowering prescription drug costs for Americans a priority, and this commitment is a step in the right direction,” CMS Administrator Dr. Mehmet Oz told FOX Business.

“By making negotiated drug prices available alongside cash prices on TrumpRx, this agreement will give patients greater visibility into how much they’re paying and help them find the best possible deal,” Oz explained. “That’s the kind of transparency we need to boost competition, drive down costs, and deliver better value for American patients.”

AMERICANS SAVE MORE THAN $700M ON PRESCRIPTION MEDICATIONS THROUGH TRUMPRX, WHITE HOUSE SAYS

The arrangement will list cash prices on TrumpRx alongside the plan benefit price for the same prescription at an in-network pharmacy. (Lindsey Nicholson/UCG/Universal Images Group via Getty Images)

The nine major PBMs that are participating include CarelonRx, CVS Health, Express Scripts, Humana, MedImpact Healthcare Systems, Navitus Health Solutions, OptumRx, Prime Therapeutics and WellDyne. Another PBM, VytlOne, is also joining the effort.

Patients will be able to see TrumpRx prices if they’re enrolled in plans from those PBMs, including commercial, Medicare and Medicaid plans. The arrangement will cover all drugs that have a price on TrumpRx – either a presidential deal or a standard price.

PRESIDENT LAUNCHES TRUMPRX.GOV WEBSITE OFFERING AMERICANS DISCOUNTED PRESCRIPTION DRUG PRICES: ‘HISTORIC’

CMS Administrator Mehmet Oz said the deal will boost price transparency for consumers. (Tierney L. Cross/Bloomberg via Getty Images)

“Consumers and patients are better off when they have more options and a clear view of their costs,” said PCMA CEO David Marin. “If there are times when a product is cheapest on TrumpRx, patients should know that. This administration has embraced the use of real-time benefit tools to give patients more information, and we strongly embrace this technology.”

“This commitment will allow consumers to compare options and make better informed choices about costs and where they access prescription drugs. It’s a no-brainer for our industry and for American families,” Marin added.

TWO MAJOR DRUG COMPANIES ARE THE LATEST TO JOIN TRUMPRX

The Trump administration launched the TrumpRx website earlier this year. (Pool / Fox News)

PCMA noted that the nine PBMs participating in this announcement are expected to provide price transparency on their benefit platforms, though some may do so in other ways.

Some of the PBMs will use their Real Time Benefit Tools to display the cash price available on TrumpRx compared with the cost of the prescription through their plan’s coverage benefit at a network pharmacy, while others may pull in the TrumpRx pricing using other methods.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Shein has lost its High Court claim against rival Temu over the alleged copyright infringement of photographs of its clothing, with Judge Kelyn Bacon ruling on Thursday that the online fast-fashion group’s claims had failed.

The case, which went to trial in London in May, centred on product photographs that Shein said had been used on Temu’s platform to advertise copies of Shein’s own-brand clothing. Shein accused Temu of breaching its copyright “on an industrial scale” and of using the images to “piggy-back” on a more established competitor.

Temu, which is owned by PDD Holdings, denied the allegations and argued that Shein was using litigation to stifle competition.

In her written ruling, Judge Bacon rejected Shein’s argument that Temu had authorised infringement by the third-party merchants who uploaded the photographs to its website, noting that Temu “prohibits merchants from uploading infringing content”. Shein did not pursue a separate argument that Temu had itself reproduced the photographs, the judge said, because Temu’s servers are located outside the United Kingdom.

The judge also found that, even if infringement had been established, Temu could have relied on the hosting defence, which shields online platforms acting as intermediaries from liability for content uploaded by third parties where they lack knowledge of the infringement.

“In so far as any infringements could be established in this case, Temu did not have either actual knowledge of the infringements or awareness of facts or circumstances from which the infringements would have been apparent,” Judge Bacon said.

A Shein spokesperson said there was no dispute that Shein owned the thousands of photographs it had sued over, or that they had appeared on Temu’s website. “Yet despite copying on an industrial scale, it has avoided liability in the UK simply because the servers supporting its UK website happen to sit in Ireland,” the spokesperson said.

Elise Cant, associate and trade mark attorney at intellectual property firm Marks & Clerk, said the court had found Temu’s role in relation to the use of the photographs to be of a “mere technical, automatic and passive nature”.

“The decision is likely to be welcomed by market-place based retailers although traditional retailers may view it less favourably,” Cant said. “It provides greater legal certainty for online marketplaces by confirming that platforms such as Temu which play a passive intermediary role in the advertisement and sale of goods on their website are less likely to face liability for infringing content uploaded by third-party sellers.”

Cant added that the ruling “may make it more difficult for traditional retailers and rights holders to pursue infringement claims against marketplace operators where infringing product listings are uploaded by independent sellers, potentially shifting the focus of enforcement efforts towards the sellers themselves rather than the platforms that host their listings”.

The judgment comes as both platforms face wider scrutiny in Britain. UK retailers have pressed the government to fast-track a tax crackdown on low-value imports sold by Shein and Temu, while Shein recently reported a $99m quarterly loss ahead of a planned Hong Kong listing.

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

• Unlimited access to WA’s most trusted business journalism
• Data & Insights — detailed profiles of WA companies, people, projects and deals
• MyBN — a personalised feed based on the companies, people and sectors you follow
• Special publications and industry reports
• Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

• Look up detailed profiles of WA companies, including financials, directors and ownership
• Find decision-makers and track their career movements
• Research live and completed projects across WA industries
• Monitor deals, appointments and market activity
• Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

• Executives and directors tracking competitors, clients and market movements
• Investors and advisers researching companies, deals and industry trends
• Consultants and professionals staying across sectors relevant to their clients
• Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

We’re happy to help.
Get in touch
and our team will come back to you.